These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22489720)

  • 1. Functional, genetic and biochemical biomarkers of peripheral arterial disease.
    Charakida M; Masi S; Tousoulis D
    Curr Med Chem; 2012; 19(16):2497-503. PubMed ID: 22489720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.
    Poredoš P; Šabovič M; Božič Mijovski M; Nikolajević J; Antignani PL; Paraskevas KI; Mikhailidis DP; Blinc A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Biomarkers in Peripheral Artery Disease: Diagnosis, Prognosis, and Therapeutic Challenges.
    Ozaki Y; Imanishi T; Akasaka T
    Curr Med Chem; 2015; 22(23):2744-53. PubMed ID: 26122499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model.
    Downing KP; Nead KT; Kojima Y; Assimes T; Maegdefessel L; Quertermous T; Cooke JP; Leeper NJ
    Vasc Med; 2014 Feb; 19(1):3-8. PubMed ID: 24323119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM; Weitzman M
    Vasc Med; 2016 Apr; 21(2):105-12. PubMed ID: 26762418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent peripheral arterial disease and inflammatory burden.
    Cauley JA; Kassem AM; Lane NE; Thorson S;
    BMC Geriatr; 2016 Dec; 16(1):213. PubMed ID: 27938334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.
    Koopal C; Geerlings MI; Muller M; de Borst GJ; Algra A; van der Graaf Y; Visseren FL;
    Atherosclerosis; 2016 Mar; 246():187-92. PubMed ID: 26800308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase.
    Morishita T; Uzui H; Nakano A; Mitsuke Y; Geshi T; Ueda T; Lee JD
    J Atheroscler Thromb; 2012; 19(2):149-58. PubMed ID: 22123215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of biomarkers and genetics in peripheral arterial disease.
    McDermott MM; Lloyd-Jones DM
    J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers in peripheral arterial disease.
    Stone PA; Yacoub M
    Semin Vasc Surg; 2014 Dec; 27(3-4):148-51. PubMed ID: 26073823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders.
    Signorelli SS; Marino E; Scuto S; Di Raimondo D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review).
    Signorelli SS; Fiore V; Malaponte G
    Int J Mol Med; 2014 Apr; 33(4):777-83. PubMed ID: 24535646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and Genetics in Peripheral Artery Disease.
    Hazarika S; Annex BH
    Clin Chem; 2017 Jan; 63(1):236-244. PubMed ID: 27872083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein.
    Zhou Y; Ni Z; Zhang J; Zhang W; Wu Q; Shen G; Wang Y; Qian J
    Vasc Med; 2013 Apr; 18(2):85-91. PubMed ID: 23609129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Mediators Across the Spectrum of Ankle-Brachial Index.
    Ozkaramanli Gur D; Gur O; Guzel S; Akyuz A; Gurkan S; Alpsoy S; Gulec NS; Koc F
    J Atheroscler Thromb; 2019 Apr; 26(4):351-361. PubMed ID: 30249941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do novel risk biomarkers reflect the severity of peripheral arterial disease?
    Khandanpour N; Jennings B; Armon MP; Wright A; Willis G; Clark A; Meyer FJ
    Angiology; 2011 Feb; 62(2):126-33. PubMed ID: 20834026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease.
    Singh TP; Morris DR; Smith S; Moxon JV; Golledge J
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):220-233. PubMed ID: 28666785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].
    Rada C; Oummou S; Merzouk F; Amarir B; Boussabnia G; Bougrini H; Benzaroual D; Elkarimi S; Elhattaoui M
    J Mal Vasc; 2016 Dec; 41(6):353-357. PubMed ID: 27865565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in peripheral arterial disease (PAD).
    Signorelli SS; Anzaldi M; Fiore V
    Curr Pharm Des; 2012; 18(28):4350-7. PubMed ID: 22390644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review for the screening for peripheral arterial disease in asymptomatic patients.
    Alahdab F; Wang AT; Elraiyah TA; Malgor RD; Rizvi AZ; Lane MA; Prokop LJ; Montori VM; Conte MS; Murad MH
    J Vasc Surg; 2015 Mar; 61(3 Suppl):42S-53S. PubMed ID: 25721066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.